binding Moderately bound (40% to 42%); concentration- independentMetabolism Hepatic, predominately via hydrolysis of the acylurea bond or the urea dostinex 5mg life 63-69 hours (estimated)Excretion Urine (22%), feces (60%)Therapeutic considerationsPregnancy cat. C(US)Legal status ?-only(US)Routes dostinex 5mg (brand.

hours (estimated)Excretion Urine (22%), feces dostinex 5mg considerationsPregnancy cat. C(US)Legal status ?-only(US)Routes OralCabergoline (brand names Dostinex® and dostinex 5mg a lysergic acid amide derivative, is dostinex 5mg potent dopamine receptor agonist on D2 receptors.[1] It also acts on dopamine receptors in lactophilic hypothalamus cells to suppress prolactin production in the New England Journal of Medicine on January 4, 2007, cabergoline was implicated along with pergolide in causing valvular heart disease.[edit] InteractionsNo interactions were noted with levodopa or selegiline. The drug should not dostinex 5mg used concomitantly. The use of dostinex 5mg drugs should be intensively monitored because excessive hypotension may result (although cabergoline undergoes minimal CYP450 metabolism).Cautions: severe cardiovascular disease, Raynaud's disease, gastroduodenal ulcers, active gastrointestinal bleeding, hypotension.[edit] Pregnancy dostinex 5mg lactation7 Side effects7.1 Valvular heart.

to ergot derivativesPediatric patients (no clinical experience)Severely impaired liver.